Q: I read your December response on this stock. It seems that their vaporizer product line required appropriate distribution channels to generate realistic returns. Apparently, the company has entered into a joint venture with one of the weed companies,which should bolster sales volumes.
Although still a high risk investment, the stock might probably be more palatable at this point. Would you agree?
Z
Although still a high risk investment, the stock might probably be more palatable at this point. Would you agree?
Z